Akero Therapeutics Inc
(AKRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,831 | -112,033 | -88,974 | -53,432 | -26,029 |
| Depreciation Amortization | -1,157 | 235 | 325 | 219 | 146 |
| Accounts payable and accrued liabilities | -631 | 968 | -708 | 145 | -2,247 |
| Other Working Capital | -3,044 | -4,459 | 2,258 | 3,273 | -348 |
| Other Operating Activity | 6,031 | 22,772 | 20,090 | 7,410 | 5,602 |
| Operating Cash Flow | $-24,632 | $-92,517 | $-67,009 | $-42,385 | $-22,876 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,590 | -63,825 | 37,620 | 34,620 | 22,750 |
| Investing Cash Flow | $17,590 | $-63,825 | $37,620 | $34,620 | $22,750 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 10,000 | 10,000 | 10,000 | 0 |
| Common Stock Issued | 456 | 246,496 | 243,607 | 25,325 | 147 |
| Other Financing Activity | -303 | -864 | -698 | -316 | -15 |
| Financing Cash Flow | $15,153 | $255,632 | $252,909 | $35,009 | $132 |
| Beginning Cash Position | 249,881 | 150,591 | 150,591 | 150,591 | 150,591 |
| End Cash Position | 257,992 | 249,881 | 374,111 | 177,835 | 150,597 |
| Net Cash Flow | $8,111 | $99,290 | $223,520 | $27,244 | $6 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,632 | -92,517 | -67,009 | -42,385 | -22,876 |
| Free Cash Flow | -24,632 | -92,517 | -67,009 | -42,385 | -22,876 |